Volume 30, Issue 2 (October 2023)
J Birjand Univ Med Sci. 2023, 30(2): 114-130 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Moniri Y, Moezi Bady S A, Khazaei Z, Roozegari M, Azdaki N. A comprehensive review of the diagnosis and treatment of hypertension in pregnancy based on the latest guidelines of the American Association of Obstetrics and Gynecology. Journals of Birjand University of Medical Sciences 2023; 30 (2) :114-130
URL: http://journal.bums.ac.ir/article-1-3290-en.html
URL: http://journal.bums.ac.ir/article-1-3290-en.html
1- Student Research Committee, Birjand University of Medical Sciences, Birjand, Iran
2- Cardiovascular Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran
3- Department of Obstetrics and Gynecology, Faculty of Medicine, Birjand University of Medical Sciences, Birjand, Iran
4- Cardiovascular Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran AND Razi Clinical Research Development Unit, Birjand University of Medical Sciences, Birjand, Iran ,nahidazdaki@yahoo.com
2- Cardiovascular Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran
3- Department of Obstetrics and Gynecology, Faculty of Medicine, Birjand University of Medical Sciences, Birjand, Iran
4- Cardiovascular Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran AND Razi Clinical Research Development Unit, Birjand University of Medical Sciences, Birjand, Iran ,
Abstract: (1243 Views)
The medical and surgical condition of mother during pregnancy can be affected on prenatal morbidity and mortality. Physician must have knowledge about the effects of pregnancy on the course of disease as well as the effects of disease on outcome of pregnancy and treatment of disease during pregnancy.
Hypertension is one of the common difficulties and complications during pregnancy, which leads to hospitalization. Blood pressure disorders occur in approximately 10% of pregnancies in the United States, and it accounts for 12.3% of maternal deaths. Hypertension in pregnancy is an important alarm that carries risks for both the mother and the fetus. In some cases, these complications can be life-threatening risks for both. For example, preeclampsia ranks among the top four leading causes of maternal mortality, when it is diagnosed and treated correctly it is possible to prevent adverse consequences. There are different types of high blood pressure in pregnancy that can be related to pregnancy or not related to pregnancy, and the diagnosis and management of each of them are different from each other. The purpose of this study was to provide a brief overview of definitions, diagnostic methods, risk factors, symptoms, side effects, drug and non-drug treatments, and prevention of various types of hypertension during pregnancy based on the latest American Obstetrics and Gynecology Guidelines and the latest edition of Beckman and Ling's Obstetrics and Gynecology.
*Corresponding Author: Nahid Azdaki; Emails: nahidazdaki@yahoo.com
Hypertension is one of the common difficulties and complications during pregnancy, which leads to hospitalization. Blood pressure disorders occur in approximately 10% of pregnancies in the United States, and it accounts for 12.3% of maternal deaths. Hypertension in pregnancy is an important alarm that carries risks for both the mother and the fetus. In some cases, these complications can be life-threatening risks for both. For example, preeclampsia ranks among the top four leading causes of maternal mortality, when it is diagnosed and treated correctly it is possible to prevent adverse consequences. There are different types of high blood pressure in pregnancy that can be related to pregnancy or not related to pregnancy, and the diagnosis and management of each of them are different from each other. The purpose of this study was to provide a brief overview of definitions, diagnostic methods, risk factors, symptoms, side effects, drug and non-drug treatments, and prevention of various types of hypertension during pregnancy based on the latest American Obstetrics and Gynecology Guidelines and the latest edition of Beckman and Ling's Obstetrics and Gynecology.
*Corresponding Author: Nahid Azdaki; Emails: nahidazdaki@yahoo.com
You can also search for this author in: PubMed ResearchGate Scopus Google Scholar Google Scholar Profile
Type of Study: Review |
Subject:
Epidemiology
Received: 2023/06/10 | Accepted: 2023/10/3 | ePublished: 2023/10/2
Received: 2023/06/10 | Accepted: 2023/10/3 | ePublished: 2023/10/2
References
1. Croke L. Gestational hypertension and preeclampsia: a practice bulletin from ACOG. American family physician. 2019; 100(10):649-50. https://www.aafp.org/pubs/afp/issues/2019/1115/p649.html
2. Yoder SR, Thornburg LL, Bisognano JD. Hypertension in pregnancy and women of childbearing age. Am J Med. 2009; 122(10): 890-5. DOI: 10.1016/j.amjmed.2009.03.036 [DOI:10.1016/j.amjmed.2009.03.036] [PMID]
3. Hauth JC, Ewell MG, Levine RJ, Esterlitz JR, Sibai B, Curet LB, et al. Pregnancy outcomes in healthy nulliparas who developed hypertension. Obstet Gynecol. 2000; 95(1): 24-8. DOI: 10.1016/s0029-7844(99)00462-7 [DOI:10.1016/S0029-7844(99)00462-7] [PMID]
4. Ford ND, Cox S, Ko JY, Ouyang L, Romero L, Colarusso T, et al. Hypertensive disorders in pregnancy and mortality at delivery hospitalization-United States, 2017-2019. MMWR Morb Mortal Wkly Rep. 2022; 71(17): 585-91. DOI: 10.15585/mmwr.mm7117a1 [DOI:10.15585/mmwr.mm7117a1] [PMID] []
5. MacKay AP, Berg CJ, Atrash HK. Pregnancy-related mortality from preeclampsia and eclampsia. Obstet Gynecol. 2001; 97(4): 533-8. DOI: 10.1016/s0029-7844(00)01223-0 [DOI:10.1016/S0029-7844(00)01223-0] [PMID]
6. Abalos E, Cuesta C, Grosso AL, Chou D, Say L. Global and regional estimates of preeclampsia and eclampsia: a systematic review. Eur J Obstet Gynecol Reprod Biol. 2013; 170(1): 1-7. DOI: 10.1016/j.ejogrb.2013.05.005 [DOI:10.1016/j.ejogrb.2013.05.005] [PMID]
7. Azdaki N, Maleki MH, Kazemi T, Moezi SA, Moghaddam HRM. V/Q scans and computerized tomography pulmonary angiography in pulmonary emboli in pregnancy: Superiority for fetal or mother. Journal of Research in Medical Sciences: J Res Med Sci. 2014; 19(7): 683-4. PMCID: PMC4214031[Persian]
8. MacKay AP, Berg CJ, Liu X, Duran C, Hoyert DL. Changes in pregnancy mortality ascertainment: United States, 1999-2005. Obstet Gynecol. 2011; 118(1): 104-10. DOI: 10.1097/AOG.0b013e31821fd49d [DOI:10.1097/AOG.0b013e31821fd49d] [PMID]
9. Azdaki N, Moezi Bady SA, Soltani M, Rahimi SM, Kazemi T, Khazaei Z. The Necessity of Preventing Venous Thromboembolism in Pregnancy: Designing an Application Software. J Birjand Univ Med Sci. 2019; 26(4): 372-5. [Persian] DOI: 10.32592/JBirjandUnivMedSci.2019.26.4.109 [Persian] [DOI:10.32592/JBirjandUnivMedSci.2019.26.4.109]
10. Aukes AM, Arion K, Bone JN, Li J, Vidler M, Bellad MB, et al. Causes and circumstances of maternal death: a secondary analysis of the Community-Level Interventions for Pre-eclampsia (CLIP) trials cohort. Lancet Glob Health. 2021; 9(9): e1242-e51. DOI: 10.1016/S2214-109X(21)00263-1 [DOI:10.1016/S2214-109X(21)00263-1] [PMID]
11. Beckmann CR, Herbert W, Laube D, Ling F, Smith R. Obstetrics and gynecology: 7th ed. Lippincott Williams & Wilkins; 2013. URL: https://books.google.com/books?hl=en&lr=&id=dD-emqhOXa0C&oi=fnd&pg=PR1&dq=Obstetrics+and+gynecology:+Lippincott+Williams+%26+Wilkins%3B+2013.&ots=yP3c9kQT4V&sig=HTWKDu6UlSE2VeK7Xu93Sv80xyk#v=onepage&q=Obstetrics%20and%20gynecology%3A%20Lippincott%20Williams%20%26%20Wilkins%3B%202013.&f=false
12. Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol. 2003; 102(1): 181-92. DOI: 10.1016/s0029-7844(03)00475-7 [DOI:10.1016/S0029-7844(03)00475-7] [PMID]
13. Gaillard R, Steegers EA, Hofman A, Jaddoe VW. Associations of maternal obesity with blood pressure and the risks of gestational hypertensive disorders. The Generation R Study. J Hypertens. 2011; 29(5): 937-44. DOI: 10.1097/HJH.0b013e328345500c [DOI:10.1097/HJH.0b013e328345500c] [PMID]
14. Ferrazzani S, De Carolis S, Pomini F, Testa AC, Mastromarino C, Caruso A. The duration of hypertension in the puerperium of preeclamptic women: relationship with renal impairment and week of delivery.Am J Obstet Gynecol. 1994; 171(2): 506-12. DOI: 10.1016/0002-9378(94)90290-9 [DOI:10.1016/0002-9378(94)90290-9] [PMID]
15. Ying W, Catov JM, Ouyang P. Hypertensive disorders of pregnancy and future maternal cardiovascular risk. J Am Heart Assoc. 2018; 7(17): e009382. DOI: 10.1161/JAHA.118.009382 [DOI:10.1161/JAHA.118.009382] [PMID] []
16. Villar J, Carroli G, Wojdyla D, Abalos E, Giordano D, Ba'aqeel H, et al. Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions? Am J Obstet Gynecol. 2006; 194(4): 921-31. DOI: 10.1016/j.ajog.2005.10.813 [DOI:10.1016/j.ajog.2005.10.813] [PMID]
17. Silver HM, Seebeck M, Carlson R. Comparison of total blood volume in normal, preeclamptic, and nonproteinuric gestational hypertensive pregnancy by simultaneous measurement of red blood cell and plasma volumes. Am J Obstet Gynecol. 1998; 179(1): 87-93. DOI: 10.1016/s0002-9378(98)70255-8 [DOI:10.1016/S0002-9378(98)70255-8] [PMID]
18. Hjartardottir S, Leifsson BG, Geirsson RT, Steinthorsdottir V. Recurrence of hypertensive disorder in second pregnancy. Am J Obstet Gynecol. 2006; 194(4): 916-20. DOI: 10.1016/j.ajog.2005.10.819 [DOI:10.1016/j.ajog.2005.10.819] [PMID]
19. Ros HS, Cnattingius S, Lipworth L. Comparison of risk factors for preeclampsia and gestational hypertension in a population-based cohort study. Am J Epidemiol. 1998; 147(11): 1062-70. DOI: 10.1093/oxfordjournals.aje.a009400 [DOI:10.1093/oxfordjournals.aje.a009400] [PMID]
20. Valensise H, Vasapollo B, Novelli G, Pasqualetti P, Galante A, Arduini D. Maternal total vascular resistance and concentric geometry: a key to identify uncomplicated gestational hypertension. BJOG: An International Journal of Obstetrics & Gynaecology. 2006; 113(9): 1044-52. DOI: 10.1111/j.1471-0528.2006.01013.x [DOI:10.1111/j.1471-0528.2006.01013.x] [PMID]
21. Noori M, Donald AE, Angelakopoulou A, Hingorani AD, Williams DJ. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension. Circulation. 2010; 122(5): 478-87. DOI: 10.1161/CIRCULATIONAHA.109.895458[Persian] [DOI:10.1161/CIRCULATIONAHA.109.895458] [PMID]
22. Bellomo G, Venanzi S, Saronio P, Verdura C, Narducci PL. Prognostic significance of serum uric acid in women with gestational hypertension. Hypertension. 2011; 58(4): 704-8. DOI: 10.1161/HYPERTENSIONAHA.111.177212 [DOI:10.1161/HYPERTENSIONAHA.111.177212] [PMID]
23. Wu Y, Xiong X, Fraser WD, Luo Z-C. Association of uric acid with progression to preeclampsia and development of adverse conditions in gestational hypertensive pregnancies. Am J Hypertens. 2012; 25(6): 711-7. DOI: 10.1038/ajh.2012.18 [DOI:10.1038/ajh.2012.18] [PMID]
24. Vischer AS, Burkard T. Principles of Blood Pressure Measurement-Current Techniques, Office vs Ambulatory Blood Pressure Measurement. Adv Exp Med Biol. 2017: 85-96. DOI: 10.1007/5584_2016_49 [DOI:10.1007/5584_2016_49] [PMID]
25. Moezi Bady SA, Kazemi T, Mashreghi-Moghadam H, Azdaki N, Partovi N, Hanafi Bojd N, et al. A comprehensive overview of the diagnosis and treatment of hypertension based on the latest hypertension guidelines. J Birjand Univ Med Sci. 2021; 28(3): 194-221. [Persian] DOI: 10.32592/JBirjandUnivMedSci.2021.28.3.100 [DOI:10.32592/JBirjandUnivMedSci.2021.28.3.100]
26. khaledi S, Bagheri Saveh MI, Dehvan F, karimi p, Mahmoodi P. The Effect of Self-Management Program on Adherence to Treatment Regimen in Patients with Hypertension. Sci. J. Kurd. Univ. Med. Sci. 2023; 28(2): 110-21. [Persian] URL: http://sjku.muk.ac.ir/article-1-7411-en.html[Persian] [DOI:10.61186/sjku.28.2.110]
27. Tita AT, Szychowski JM, Boggess K, Dugoff L, Sibai B, Lawrence K, et al. Treatment for mild chronic hypertension during pregnancy. N Engl J Med. 2022; 386(19): 1781-92. DOI: 10.1056/NEJMoa2201295 [DOI:10.1056/NEJMoa2201295] [PMID] []
28. Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin Summary, Number 222. Obstet Gynecol. 2020; 135(6): 1492-5. DOI: 10.1097/AOG.0000000000003892 [DOI:10.1097/AOG.0000000000003892] [PMID]
29. Obstetricians ACo, Gynecologists. ACOG Practice Bulletin No. 203: chronic hypertension in pregnancy. Obstetrics and gynecology. 2019; 133(1): e26-e50. DOI: 10.1097/AOG.0000000000003020 [DOI:10.1097/AOG.0000000000003020] [PMID]
30. Bady SAM, Kazemi T, Mashreghi-Moghadam H, Azdaki N, Partovi N, Bojd NH, et al. A comprehensive overview of the diagnosis and treatment of hypertension based on the latest hypertension guidelines. J Birjand Univ Med Sci. 2021; 28(3): 194-221. [Persian] DOI: 10.32592/JBirjandUnivMedSci.2021.28.3.100 [DOI:10.32592/JBirjandUnivMedSci.2021.28.3.100]
31. Bellos I, Pergialiotis V, Papapanagiotou A, Loutradis D, Daskalakis G. Comparative efficacy and safety of oral antihypertensive agents in pregnant women with chronic hypertension: a network metaanalysis. Am J Obstet Gynecol. 2020; 223(4): 525-37. DOI: 10.1016/j.ajog.2020.03.016 [DOI:10.1016/j.ajog.2020.03.016] [PMID]
32. Gillon TE, Pels A, von Dadelszen P, MacDonell K, Magee LA. Hypertensive disorders of pregnancy: a systematic review of international clinical practice guidelines. PloS one. 2014; 9(12): e113715. DOI: 10.1371/journal.pone.0113715 [DOI:10.1371/journal.pone.0113715] [PMID] []
33. Cruz MO, Gao W, Hibbard JU. What is the optimal time for delivery in women with gestational hypertension? Am J Obstet Gynecol. 2012; 207(3): 214. e1-6. DOI: 10.1016/j.ajog.2012.06.009 [DOI:10.1016/j.ajog.2012.06.009] [PMID]
34. Spong CY, Mercer BM, D'Alton M, Kilpatrick S, Blackwell S, Saade G. Timing of indicated late-preterm and early-term birth. Obstet Gynecol. 2011; 118(2 Pt 1): 323-33. DOI: 10.1097/AOG.0b013e3182255999 [DOI:10.1097/AOG.0b013e3182255999] [PMID] []
35. Benigni A, Gregorini G, Frusca T, Chiabrando C, Ballerini S, Valcamonico A, et al. Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for ppregnancy-induced hypertension. N Engl J Med. 1989; 321(6): 357-62. DOI: 10.1056/NEJM198908103210604 [DOI:10.1056/NEJM198908103210604] [PMID]
36. Schiff E, Peleg E, Goldenberg M, Rosenthal T, Ruppin E, Tamarkin M, et al. The Use of Aspirin to Prevent Ppregnancy-Induced Hypertension and Lower the Ratio of Thromboxane A2 to Prostcyclin in Relatively High Risk Pregnancies. N Engl J Med. 1989; 321(6): 351-6. DOI: 10.1056/NEJM198908103210603 [DOI:10.1056/NEJM198908103210603] [PMID]
37. Wallenburg H, Makovitz J, Dekker G, Rotmans P. Low-dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidae. Lancet. 1986; 327(8471): 1-3. DOI: 10.1016/s0140-6736(86)91891-x [DOI:10.1016/S0140-6736(86)91891-X] [PMID]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Attribution-NoneCommercial CC BY-NC